| [1] |
REN Y, KEBEDE M A, OGUNLEYE A A, et al. Burden of lymphedema in long-term breast cancer survivors by race and age[J]. Cancer, 2022, 128(23): 4119-4128.
doi: 10.1002/cncr.34489
pmid: 36223240
|
| [2] |
BROWN S, DAYAN J H, CORIDDI M, et al. Doxycycline for the treatment of breast cancer-related lymphedema[J]. Front Pharmacol, 2022, 13: 1028926.
doi: 10.3389/fphar.2022.1028926
|
| [3] |
LIU Y F, LIU J E, ZHU Y, et al. Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors[J]. Support Care Cancer, 2021, 29(9): 5435-5445.
|
| [4] |
BAHANESTEH A, YARMOHAMMADI H, SHAHSHENAS S, et al. Risk factors for severity of breast cancer-related lymphedema[J]. Radiat Oncol, 2025, 20(1): 81.
doi: 10.1186/s13014-025-02663-2
|
| [5] |
谢娜, 贾杰. 乳腺癌术后上肢淋巴水肿发生及康复机制[J]. 康复学报, 2017, 27(6): 54-58.
|
|
XIE N, JIA J. Progress on development and rehabilitation mechanism of upper extremity lymphedema after radical mastectomy[J]. Rehabil Med, 2017, 27(6): 54-58.
|
| [6] |
中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J]. 中国癌症杂志, 2023, 33 (12): 1092-1187.
doi: 10.19401/j.cnki.1007-3639.2023.12.004
|
| [7] |
AMIN M B, EDGE S B, GREENE F L, et al. AJCC Cancer Staging Manual[M]. 8th ed. New York: Springer, 2016.
|
| [8] |
WANG H, SHEN L, LIU T, et al. Circumference-based criteria for detection of secondary arm lymphedema for Chinese women[J]. Lymphat Res Biol, 2017, 15(3): 262-267.
doi: 10.1089/lrb.2017.0002
pmid: 28749717
|
| [9] |
国家肿瘤质控中心乳腺癌专家委员会, 北京乳腺病防治学会健康管理专业委员会. 中国乳腺癌随诊随访与健康管理指南(2022版)[J]. 中华肿瘤杂志, 2022, 44(1): 1-28.
|
| [10] |
沈莉, 王鹤玮, 陈栎屹, 等. 筋膜松解手法联合运动疗法对乳腺癌术后腋网综合征患者的疗效观察[J]. 中国医刊, 2024, 59(3): 324-329.
|
| [11] |
MCEVOY M P, RAVETCH E, PATEL G, et al. Prevention of breast cancer-related lymphedema[J]. Clin Breast Cancer, 2021, 21(2): 128-142.
doi: 10.1016/j.clbc.2021.02.009
|
| [12] |
ZHANG X, OLIVERI J M, PASKETT E D. Features, predictors, and treatment of breast cancer-related lymphedema[J]. Curr Breast Cancer Rep, 2020, 12(4): 244-254.
doi: 10.1007/s12609-020-00381-0
|
| [13] |
FOURGEAUD C, VIGNES S. New insights in breast cancer-related lymphedema[J]. J Med Vasc, 2024, 49(3/4): 135-140.
|
| [14] |
SHARIFI N, AHMAD S. Breast cancer-related lymphedema: a critical review on recent progress[J]. Surg Oncol, 2024, 56: 102124.
doi: 10.1016/j.suronc.2024.102124
|
| [15] |
RAFN B S, CHRISTENSEN J, LARSEN A, et al. Prospective surveillance for breast cancer-related arm lymphedema: a systematic review and meta-analysis[J]. J Clin Oncol, 2022, 40(9): 1009-1026.
|
| [16] |
SHAH C, ASHA W, VICINI F. Current diagnostic tools for breast cancer-related lymphedema[J]. Curr Oncol Rep, 2023, 25(3): 151-154.
doi: 10.1007/s11912-023-01357-w
|
| [17] |
MAYROVITZ H N. Noninvasive measurements of breast cancer-related lymphedema[J]. Cureus, 2021, 13(11): e19813.
|
| [18] |
耿文慧, 周严红, 尹俊普, 等. 乳腺癌术后肩关节活动度分析[J]. 中国康复理论与实践, 2025, 31(3): 356-364.
doi: 10.3969/j.issn.1006-9771.2025.03.013
|
|
GENG W H, ZHOU Y H, YIN J P, et al. Shoulder joint range of motion after operation for breast cancer[J]. Chin J Rehabil Theory Pract, 2025, 31(3): 356-364.
|
| [19] |
GONZÁLEZ-RUBINO J B, VINOLO-GIL M J, MARTÍN-VALERO R. Effectiveness of physical therapy in axillary web syndrome after breast cancer: a systematic review and meta-analysis[J]. Support Care Cancer, 2023, 31(5): 257.
|
| [20] |
张浩, 刘锐芮, 朱琳, 等. 中国女性乳腺癌相关淋巴水肿危险因素的Meta分析[J]. 中国全科医学, 2021, 24(26): 3349-3358, 3376.
doi: 10.12114/j.issn.1007-9572.2021.01.206
|
|
ZHANG H, LIU R R, ZHU L, et al. Risk factors for breast cancer-related lymphedema in Chinese women: a meta-analysis[J]. Chin Gener Prac, 2021, 24(26): 3349-3358, 3376.
|